These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9198195)
1. Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. INSERM Network on Molecular Abnormalities in von Willebrand Disease. Meyer D; Fressinaud E; Gaucher C; Lavergne JM; Hilbert L; Ribba AS; Jorieux S; Mazurier C Thromb Haemost; 1997 Jul; 78(1):451-6. PubMed ID: 9198195 [TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A; Berneman Z; Schroyens W; Michiels JJ Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359 [TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of von Willebrand disease. Mazurier C; Ribba AS; Gaucher C; Meyer D Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650 [TBL] [Abstract][Full Text] [Related]
5. Understanding von Willebrand's disease from gene defects to the patients. Zhang Z; Blombäck M; Anvret M J Intern Med Suppl; 1997; 740():115-9. PubMed ID: 9350192 [TBL] [Abstract][Full Text] [Related]
6. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene. Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361 [TBL] [Abstract][Full Text] [Related]
7. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease. Casaña P; Martínez F; Haya S; Tavares A; Aznar JA Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of inherited von Willebrand disease: a clinical perspective. Federici AB Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566 [TBL] [Abstract][Full Text] [Related]
9. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1. Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353 [TBL] [Abstract][Full Text] [Related]
10. Von Willebrand disease - phenotype versus genotype: deficiency versus disease. Lillicrap D Thromb Res; 2007; 120 Suppl 1():S11-6. PubMed ID: 17490730 [TBL] [Abstract][Full Text] [Related]
11. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease. Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885 [TBL] [Abstract][Full Text] [Related]
12. The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network. Keeney S; Bowen D; Cumming A; Enayat S; Goodeve A; Hill M; Haemophilia; 2008 Sep; 14(5):1099-111. PubMed ID: 18637846 [TBL] [Abstract][Full Text] [Related]
13. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1. Schneppenheim R; Budde U; Krey S; Drewke E; Bergmann F; Lechler E; Oldenburg J; Schwaab R Thromb Haemost; 1996 Oct; 76(4):598-602. PubMed ID: 8903002 [TBL] [Abstract][Full Text] [Related]
14. Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide. Hilbert L; Nurden P; Caron C; Nurden AT; Goudemand J; Meyer D; Fressinaud E; Mazurier C; Thromb Haemost; 2006 Sep; 96(3):290-4. PubMed ID: 16953269 [TBL] [Abstract][Full Text] [Related]
15. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences. Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467 [TBL] [Abstract][Full Text] [Related]
16. Type 2N von Willebrand disease: rapid genetic diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F)--detection of a novel candidate type 2N mutation: C2810T (R854W). Bowen DJ; Standen GR; Mazurier C; Gaucher C; Cumming A; Keeney S; Bidwell J Thromb Haemost; 1998 Jul; 80(1):32-6. PubMed ID: 9684781 [TBL] [Abstract][Full Text] [Related]
17. Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling. Nitu-Whalley IC; Riddell A; Lee CA; Pasi KJ; Owens D; Enayat MS; Perkins SJ; Jenkins PV Thromb Haemost; 2000 Dec; 84(6):998-1004. PubMed ID: 11154147 [TBL] [Abstract][Full Text] [Related]
18. Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function. Meyer D; Fressinaud E; Hilbert L; Ribba AS; Lavergne JM; Mazurier C Best Pract Res Clin Haematol; 2001 Jun; 14(2):349-64. PubMed ID: 11686104 [TBL] [Abstract][Full Text] [Related]
19. Expression of two type 2N von Willebrand disease mutations identified in exon 18 of von Willebrand factor gene. Hilbert L; Jorieux S; Fontenay-Roupie M; Guicheteau M; Fressinaud E; Meyer D; Mazurier C; Br J Haematol; 2004 Oct; 127(2):184-9. PubMed ID: 15461624 [TBL] [Abstract][Full Text] [Related]
20. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients. Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]